What impact does ritlecitinib’s dual inhibition of JAK and TEC pathways have on the immune response in alopecia areata?
Featuring Glynis Ablon, MD |
Associate Clinical Professor
University of California, Los Angeles
Ablon Skin Institute & Research Center
Los Angeles, CA
Related CME
Related Media
Powered by Polaris TM